Neuropathix Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of NPTX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies6,518,0956.67%
VC/PE Firms6,817,0676.98%
Public Companies20,342,07620.8%
Individual Insiders25,918,80926.5%
General Public38,102,39639%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 10 shareholders own 61% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.8%
Medical Marijuana, Inc.
20,342,076US$6.1k0%no data
17%
Dean Petkanas
16,640,934US$5.0k0%no data
6.98%
Kettner Investments, LLC
6,817,067US$2.0k0%100.0%
6.67%
Golden Gate Capital Partners LLC
6,518,095US$2.0k0%no data
5.58%
Thomas Kikis
5,454,125US$1.6k0%no data
1.58%
Mark Corrao
1,546,875US$464.10%no data
1.56%
William Kinney
1,526,875US$458.10%no data
0.26%
Robert Malasek
250,000US$75.00%no data
0.26%
Timothy Scott
250,000US$75.00%no data
0.26%
Blake Schroeder
250,000US$75.00%no data